机构

• 上海药物研究所 [19]
• 合肥物质科学研究院 [12]
• 长春应用化学研究所 [8]
• 上海应用物理研究所 [5]
• 自动化研究所 [4]
• 宁波材料技术与工程研... [3]
• 更多

采集方式

• OAI收割 [71]
• iSwitch采集 [2]

内容类型

• 期刊论文 [73]

发表日期

• 2024 [2]
• 2023 [2]
• 2022 [11]
• 2021 [7]
• 2020 [4]
• 2019 [6]
• 更多

学科主题

• Chemistry [2]
• Cell Biolo... [1]
• Chemistry,... [1]
• Chemistry;... [1]
• Materials ... [1]
• Oncology [1]
• 更多

筛选

浏览/检索结果: 共73条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 10 作者:  Li, Wen-jing;  Xie, Cheng-ying;  Zhu, Xi;  Tang, Jiao;  Wang, Lei   |  收藏  |  浏览/下载：4/0  |  提交时间：2024/02/19 SIBP-03  HER3  HER3-targeted therapy  neuregulin 1  EGFR  HER2   The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors 期刊论文  OAI收割 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 卷号: 17, 期号: 1, 页码: 32 作者:  Wei, Qing;  Li, Peijing;  Yang, Teng;  Zhu, Jiayu;  Sun, Lu   |  收藏  |  浏览/下载：24/0  |  提交时间：2024/02/27 Antibody-drug conjugate  Solid tumor  Combination therapy  Immunotherapy  Targeted therapy   Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12 作者:  Lin, Ting-ting;  Xiong, Wei;  Chen, Gui-hua;  He, Yang;  Long, Li   |  收藏  |  浏览/下载：6/0  |  提交时间：2024/01/26 osimertinib resistance  targeted drug delivery  liposomes  panobinostat  tumor-associated macrophage  combination therapy   Biocompatible Ferrofluid-Based Millirobot for Tumor Photothermal Therapy in Near-Infrared-II Window 期刊论文  OAI收割 ADVANCED HEALTHCARE MATERIALS, 2023, 页码: 12 作者:  Ji, Yiming;  Bai, Xue;  Sun, Hongyan;  Wang, Luyao;  Gan, Chunyuan   |  收藏  |  浏览/下载：8/0  |  提交时间：2024/02/22 ferrofluid robots  biocompatibility  targeted therapy   Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文  OAI收割 FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13 作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang   |  收藏  |  浏览/下载：25/0  |  提交时间：2022/12/22 HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies   Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China 期刊论文  OAI收割 THORACIC CANCER, 2022 作者:  Xu, Chunwei;  Si, Lu;  Wang, Wenxian;  Li, Ziming;  Song, Zhengbo   |  收藏  |  浏览/下载：39/0  |  提交时间：2022/12/22 fusion  precision medicine  solid tumor  targeted therapy  tyrosine receptor kinase   Neoadjuvant Savolitinib targeted therapy stage IIIA-N2 primary lung adenocarcinoma harboring MET Exon 14 skipping mutation: A case report 期刊论文  OAI收割 FRONTIERS IN ONCOLOGY, 2022, 卷号: 12 作者:  Fu, Meng;  Feng, Chun-Mei;  Xia, Da-Qing;  Ji, Zi-Mei;  Xia, Huai-Ling   |  收藏  |  浏览/下载：21/0  |  提交时间：2022/12/23 savolitinib  MET exon 14 skipping  neoadjuvant therapy  non-small cell lung cancer  targeted therapy   Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment 期刊论文  OAI收割 ACTA BIOMATERIALIA, 2022, 卷号: 147, 页码: 356-365 作者:  Huang, Xiaobei;  Mu, Ning;  Ding, Yuanfu;  Lam, Hou Wang;  Yue, Ludan   |  收藏  |  浏览/下载：17/0  |  提交时间：2022/08/22 Photodynamic-chemotherapeutic therapy  Pt(IV) prodrug  Charge -reversal  Targeted drug delivery  Controlled drug release   Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 11 作者:  Zhao, Zi-tong;  Wang, Jue;  Fang, Lei;  Qian, Xin-di;  Cai, Ying   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/08/16 nanoparticles  molecular targeted therapy  non-small cell lung cancer  dual-responsive  controlled release   Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert Statements 期刊论文  OAI收割 LIVER CANCER, 2022, 卷号: 11 作者:  Sun, Yongkun;  Zhang, Wen;  Bi, Xinyu;  Yang, Zhengqiang;  Tang, Yu   |  收藏  |  浏览/下载：38/0  |  提交时间：2022/12/23 Chinese interdisciplinary experts  Hepatocellular carcinoma  Molecular targeted therapy  Consensus